| ID |
Date |
Time |
Language |
Theme (AI-translated Themes from Japanese) |
Co-sponsoring Company(ies) |
Venue |
| LS01 |
Sep 18 (Thu) |
12:00 - 12:50 |
JPN |
The Future of Further Minimally Invasive Surgery |
Stryker Japan K.K. |
2 |
2F Crystal Garden A |
| LS02 |
Sep 18 (Thu) |
12:00 - 12:50 |
JPN |
Topics in Gynecologic Endoscopic Surgery and Strategies for Advanced Ovarian Cancer Drug Therapy |
Takeda Pharmaceutical Company Limited |
3 |
2F Crystal Garden B |
| LS03 |
Sep 18 (Thu) |
12:00 - 12:50 |
JPN |
Expanding Options with vNOTES: The Future of Minimally Invasive Gynecologic Surgery |
Applied Medical Japan K.K. |
5 |
2F Kaimon |
| LS04 |
Sep 18 (Thu) |
12:00 - 12:50 |
JPN |
“A New Vision Opened by 4K” — Evolution and Advancement of Laparoscopy and Hysteroscopy |
Olympus Marketing, lnc. |
7 |
4F Parl |
| LS05 |
Sep 18 (Thu) |
12:00 - 12:50 |
JPN |
Device Selection for a New Era: Energy Devices Required in the Reiwa Era |
B. Braun Aesculap Japan Co., Ltd. |
8 |
4F Iris |
| LS06 |
Sep 18 (Thu) |
12:00 - 12:50 |
JPN |
Milestones in Smart Laparoscopy: The Evolution of Senhance |
Asensus Surgical Japan, Inc. |
9 |
5F Ruby |
| LS07 |
Sep 19 (Fri) |
12:00 - 12:50 |
JPN |
Elucidating Immunosuppressive Mechanisms in the Tumor Microenvironment through Immune Genomic Analysis and Their Application to Cancer Immunotherapy |
MSD K.K. |
2 |
2F Crystal Garden A |
| LS08 |
Sep 19 (Fri) |
12:00 - 12:50 |
JPN |
AI that Interacts with Physicians’ Sensibility: Its Role as a Copilot — Next-Generation Surgery Pioneered by SurVis-Hys |
Jmees Inc. |
3 |
2F Crystal Garden B |
| LS09 |
Sep 19 (Fri) |
12:00 - 12:50 |
JPN |
The Future of Recurrent Cervical Cancer Treatment: Expectations for Tisotumab Vedotin and the Role of Surgery |
Genmab K.K. |
4 |
2F Amethyst |
| LS10 |
Sep 19 (Fri) |
12:00 - 12:50 |
JPN |
“No More Hesitation!” Indications, Approaches, and Secrets of Choice in Gynecologic Surgery |
KARL STORZ Endoscopy Japan K.K./MC Medical, Inc. |
5 |
2F Kaimon |
| LS11 |
 |
|
Sep 19 (Fri) |
12:00 - 12:50 |
ENG |
Technological Evolution in Robotic Gynecologic Surgery: The da Vinci 5 as a Catalyst for Paradigm Change |
Intuitive Surgical G.K. |
6 |
2F Sakurajima |
| LS12 |
Sep 19 (Fri) |
12:00 - 12:50 |
JPN |
Toward Stress-Free Surgery: From vNOTES to Robotic Surgery |
Amco Inc. |
7 |
4F Parl |
| LS13 |
Sep 19 (Fri) |
12:00 - 12:50 |
JPN |
Unraveling the Essence of Surgery from Multiple Perspectives: How Technology is Changing the Field |
Integra Japan Co., Ltd. |
8 |
4F Iris |
| LS14 |
Sep 20 (Sat) |
12:30 - 13:20 |
JPN |
Surgical Innovation Starting from the Surgical Field — Minimally Invasive Strategies for Uterine Fibroids and Endometriosis |
ASKA Pharmaceutical Co., Ltd. |
2 |
2F Crystal Garden A |
| LS15 |
Sep 20 (Sat) |
12:30 - 13:20 |
JPN |
Clinical Value Revealed Beyond 1,500 Cases of Gynecologic Surgery with hinotori™ |
Medicaroid Corporation/Sysmex Corporation |
3 |
2F Crystal Garden B |
| LS16 |
Sep 20 (Sat) |
12:30 - 13:20 |
JPN |
Diversifying Education in Robot-Assisted Surgery: How Should We Prepare for the Direct-Robot Generation? |
KAKEN PHARMACEUTICAL CO., LTD. |
4 |
2F Amethyst |
| LS17 |
Sep 20 (Sat) |
12:30 - 13:20 |
JPN |
Cutting-Edge Treatment for Dysmenorrhea: An Approach with E4/DRSP |
Fuji Pharma Co., Ltd. |
5 |
2F Kaimon |
| LS18 |
Sep 20 (Sat) |
12:30 - 13:20 |
JPN |
Visible TLH/RASH with SecuFix: From Safety and Education to Application in Challenging Cases — Let’s Share Our Challenges and Find Solutions Together |
NIPRO Corporation/Richard Wolf K.K. |
7 |
4F Parl |
| LS19 |
Sep 20 (Sat) |
12:30 - 13:20 |
JPN |
Maximizing the Benefits of vNOTES: What More Can Be Done? |
MEDICON, INC. / Becton, Dickinson and Company |
8 |
4F Iris |
